HEALY JAMES has filed 55 insider transactions across 6 companies since January 2024.
Most recent transaction: a transaction of 31603 shares of Y-mAbs Therapeutics, Inc. ($YMAB) on September 16, 2025.
Activity breakdown: 23 open-market purchases and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 16, 2025 | Y-mAbs Therapeutics, Inc. | $YMAB | HEALY JAMES | Not found | U | Common Stock | 31603 | $8.60 | 0.0000 | 45,318,028 | 100.00% | 0.07% |
| Sept. 16, 2025 | Y-mAbs Therapeutics, Inc. | $YMAB | HEALY JAMES | Not found | D | Employee Stock Option (right to buy) | 16000 | $0.00 | 0.0000 | 45,318,028 | 100.00% | 0.04% |
| Sept. 16, 2025 | Y-mAbs Therapeutics, Inc. | $YMAB | HEALY JAMES | Not found | D | Employee Stock Option (right to buy) | 33450 | $0.00 | 0.0000 | 45,318,028 | 100.00% | 0.07% |
| Sept. 16, 2025 | Y-mAbs Therapeutics, Inc. | $YMAB | HEALY JAMES | Not found | D | Employee Stock Option (right to buy) | 14545 | $0.00 | 0.0000 | 45,318,028 | 100.00% | 0.03% |
| Sept. 16, 2025 | Y-mAbs Therapeutics, Inc. | $YMAB | HEALY JAMES | Not found | D | Employee Stock Option (right to buy) | 13950 | $0.00 | 0.0000 | 45,318,028 | 100.00% | 0.03% |
| Sept. 16, 2025 | Y-mAbs Therapeutics, Inc. | $YMAB | HEALY JAMES | Not found | D | Employee Stock Option (right to buy) | 11000 | $0.00 | 0.0000 | 45,318,028 | 100.00% | 0.02% |
| Sept. 16, 2025 | Y-mAbs Therapeutics, Inc. | $YMAB | HEALY JAMES | Not found | U | Common Stock | 2194278 | $8.60 | 0.0000 | 45,318,028 | 100.00% | 4.84% |
| Sept. 16, 2025 | Y-mAbs Therapeutics, Inc. | $YMAB | HEALY JAMES | Not found | D | Employee Stock Option (right to buy) | 11000 | $0.00 | 0.0000 | 45,318,028 | 100.00% | 0.02% |
| Sept. 16, 2025 | Y-mAbs Therapeutics, Inc. | $YMAB | HEALY JAMES | Not found | D | Employee Stock Option (right to buy) | 8000 | $0.00 | 0.0000 | 45,318,028 | 100.00% | 0.02% |
| Sept. 16, 2025 | Y-mAbs Therapeutics, Inc. | $YMAB | HEALY JAMES | Not found | D | Employee Stock Option (right to buy) | 14222 | $0.00 | 0.0000 | 45,318,028 | 100.00% | 0.03% |
| Sept. 16, 2025 | Y-mAbs Therapeutics, Inc. | $YMAB | HEALY JAMES | Not found | D | Common Stock | 25080 | $0.00 | 0.0000 | 45,318,028 | 100.00% | 0.06% |
| June 30, 2025 | Y-mAbs Therapeutics, Inc. | $YMAB | HEALY JAMES | Not found | A | Common Stock | 25080 | $0.00 | 2,250,961.0000 | 45,104,476 | 1.13% | 0.06% |
| June 30, 2025 | Y-mAbs Therapeutics, Inc. | $YMAB | HEALY JAMES | Not found | A | Employee Stock Option (right to buy) | 33450 | $0.00 | 33,450.0000 | 45,104,476 | 9999.99% | 0.07% |
| June 17, 2025 | Rapport Therapeutics, Inc. | $RAPP | HEALY JAMES | Not found | A | Stock Option (Right to Buy) | 21850 | $0.00 | 21,850.0000 | 36,496,437 | 9999.99% | 0.06% |
| June 5, 2025 | BioAge Labs, Inc. | $BIOA | HEALY JAMES | Not found | A | Stock Option (Right to Buy) | 22000 | $0.00 | 22,000.0000 | 35,850,037 | 9999.99% | 0.06% |
| April 25, 2025 | Natera, Inc. | $NTRA | HEALY JAMES | Not found | A | Common Stock | 142 | $0.00 | 1,596,540.0000 | 134,750,000 | 0.01% | 0.00% |
| Jan. 31, 2025 | Natera, Inc. | $NTRA | HEALY JAMES | Not found | A | Common Stock | 114 | $0.00 | 1,596,398.0000 | 124,718,000 | 0.01% | 0.00% |
| Oct. 25, 2024 | Natera, Inc. | $NTRA | HEALY JAMES | Not found | A | Common Stock | 153 | $0.00 | 1,596,284.0000 | 123,775,000 | 0.01% | 0.00% |
| Sept. 27, 2024 | BioAge Labs, Inc. | $BIOA | HEALY JAMES | Not found | C | Series D Preferred Stock | 7310796 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Sept. 25, 2024 | BioAge Labs, Inc. | $BIOA | HEALY JAMES | Not found | A | Stock Option (Right to Buy) | 15000 | $0.00 | 15,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 27, 2024 | BioAge Labs, Inc. | $BIOA | HEALY JAMES | Not found | P | Common Stock | 26497 | $18.00 | 2,304,901.0000 | 0 | 1.16% | 0.00% |
| Sept. 27, 2024 | BioAge Labs, Inc. | $BIOA | HEALY JAMES | Not found | P | Common Stock | 21814 | $18.00 | 2,304,901.0000 | 0 | 0.96% | 0.00% |
| Sept. 27, 2024 | BioAge Labs, Inc. | $BIOA | HEALY JAMES | Not found | P | Common Stock | 18353 | $18.00 | 2,304,901.0000 | 0 | 0.80% | 0.00% |
| Sept. 27, 2024 | BioAge Labs, Inc. | $BIOA | HEALY JAMES | Not found | P | Common Stock | 11113 | $18.00 | 2,304,901.0000 | 0 | 0.48% | 0.00% |
| Sept. 27, 2024 | BioAge Labs, Inc. | $BIOA | HEALY JAMES | Not found | P | Common Stock | 588888 | $18.00 | 2,304,901.0000 | 0 | 34.32% | 0.00% |
| Sept. 27, 2024 | BioAge Labs, Inc. | $BIOA | HEALY JAMES | Not found | C | Common Stock | 1638236 | $0.00 | 1,716,013.0000 | 0 | 2106.32% | 0.00% |
| July 26, 2024 | Natera, Inc. | $NTRA | HEALY JAMES | Not found | A | Common Stock | 177 | $0.00 | 1,596,131.0000 | 122,853,000 | 0.01% | 0.00% |
| July 1, 2024 | Rapport Therapeutics, Inc. | $RAPP | HEALY JAMES | Director | P | Common Stock | 3630 | $23.08 | 1,984,651.0000 | 0 | 0.18% | 0.00% |
| July 1, 2024 | Rapport Therapeutics, Inc. | $RAPP | HEALY JAMES | Director | P | Common Stock | 3538 | $23.08 | 1,984,926.0000 | 0 | 0.18% | 0.00% |
| July 1, 2024 | Rapport Therapeutics, Inc. | $RAPP | HEALY JAMES | Director | P | Common Stock | 3565 | $24.21 | 1,988,491.0000 | 0 | 0.18% | 0.00% |
| July 1, 2024 | Rapport Therapeutics, Inc. | $RAPP | HEALY JAMES | Director | P | Common Stock | 4544 | $25.02 | 1,993,035.0000 | 0 | 0.23% | 0.00% |
| July 1, 2024 | Rapport Therapeutics, Inc. | $RAPP | HEALY JAMES | Director | P | Common Stock | 2559 | $26.06 | 1,995,594.0000 | 0 | 0.13% | 0.00% |
| July 1, 2024 | Rapport Therapeutics, Inc. | $RAPP | HEALY JAMES | Director | P | Common Stock | 3799 | $23.08 | 1,984,140.0000 | 0 | 0.19% | 0.00% |
| July 1, 2024 | Rapport Therapeutics, Inc. | $RAPP | HEALY JAMES | Director | P | Common Stock | 3828 | $24.21 | 1,987,968.0000 | 0 | 0.19% | 0.00% |
| July 1, 2024 | Rapport Therapeutics, Inc. | $RAPP | HEALY JAMES | Director | P | Common Stock | 4878 | $25.02 | 1,992,846.0000 | 0 | 0.25% | 0.00% |
| July 1, 2024 | Rapport Therapeutics, Inc. | $RAPP | HEALY JAMES | Director | P | Common Stock | 2748 | $26.06 | 1,995,594.0000 | 0 | 0.14% | 0.00% |
| July 1, 2024 | Rapport Therapeutics, Inc. | $RAPP | HEALY JAMES | Director | P | Common Stock | 3657 | $24.21 | 1,988,308.0000 | 0 | 0.18% | 0.00% |
| July 1, 2024 | Rapport Therapeutics, Inc. | $RAPP | HEALY JAMES | Director | P | Common Stock | 4661 | $25.02 | 1,992,969.0000 | 0 | 0.23% | 0.00% |
| July 1, 2024 | Rapport Therapeutics, Inc. | $RAPP | HEALY JAMES | Director | P | Common Stock | 2625 | $26.06 | 1,995,594.0000 | 0 | 0.13% | 0.00% |
| June 28, 2024 | Natera, Inc. | $NTRA | HEALY JAMES | Not found | A | Common Stock | 2964 | $0.00 | 1,595,954.0000 | 120,814,000 | 0.19% | 0.00% |
| June 12, 2024 | Bolt Biotherapeutics, Inc. | $BOLT | HEALY JAMES | Not found | A | Stock Option (Right to Buy) | 22000 | $0.00 | 22,000.0000 | 0 | 9999.99% | 0.00% |
| June 11, 2024 | Y-mAbs Therapeutics, Inc. | $YMAB | HEALY JAMES | Director | A | Common Stock | 3495 | $0.00 | 2,225,881.0000 | 43,779,456 | 0.16% | 0.01% |
| June 11, 2024 | Y-mAbs Therapeutics, Inc. | $YMAB | HEALY JAMES | Director | A | Employee Stock Option (right to buy) | 14545 | $0.00 | 14,545.0000 | 43,779,456 | 9999.99% | 0.03% |
| June 10, 2024 | Rapport Therapeutics, Inc. | $RAPP | HEALY JAMES | Not found | C | Series B Preferred Stock | 11924138 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| June 10, 2024 | Rapport Therapeutics, Inc. | $RAPP | HEALY JAMES | Not found | P | Common Stock | 470589 | $17.00 | 1,951,562.0000 | 0 | 31.78% | 0.00% |
| June 10, 2024 | Rapport Therapeutics, Inc. | $RAPP | HEALY JAMES | Not found | C | Common Stock | 1392738 | $0.00 | 1,480,973.0000 | 0 | 1578.44% | 0.00% |
| June 10, 2024 | Rapport Therapeutics, Inc. | $RAPP | HEALY JAMES | Not found | P | Common Stock | 18641 | $17.00 | 1,951,562.0000 | 0 | 0.96% | 0.00% |
| June 10, 2024 | Rapport Therapeutics, Inc. | $RAPP | HEALY JAMES | Not found | P | Common Stock | 17861 | $17.00 | 1,951,562.0000 | 0 | 0.92% | 0.00% |
| June 10, 2024 | Rapport Therapeutics, Inc. | $RAPP | HEALY JAMES | Not found | P | Common Stock | 26278 | $17.00 | 1,951,562.0000 | 0 | 1.36% | 0.00% |
| June 10, 2024 | Rapport Therapeutics, Inc. | $RAPP | HEALY JAMES | Not found | P | Common Stock | 25455 | $17.00 | 1,951,562.0000 | 0 | 1.32% | 0.00% |
| April 26, 2024 | Natera, Inc. | $NTRA | HEALY JAMES | Not found | A | Common Stock | 210 | $0.00 | 1,592,990.0000 | 120,814,000 | 0.01% | 0.00% |
| Jan. 30, 2024 | ArriVent BioPharma, Inc. | $AVBP | HEALY JAMES | Director | C | Common Stock | 1252308 | $0.00 | 1,252,308.0000 | 2,140,951 | 9999.99% | 58.49% |
| Jan. 30, 2024 | ArriVent BioPharma, Inc. | $AVBP | HEALY JAMES | Director | P | Common Stock | 444444 | $18.00 | 1,696,752.0000 | 2,140,951 | 35.49% | 20.76% |
| Jan. 30, 2024 | ArriVent BioPharma, Inc. | $AVBP | HEALY JAMES | Director | C | Series B Preferred Stock | 1252308 | $0.00 | 0.0000 | 2,140,951 | 100.00% | 58.49% |
| Jan. 26, 2024 | Natera, Inc. | $NTRA | HEALY JAMES | Not found | A | Common Stock | 264 | $63.79 | 1,592,780.0000 | 114,997,000 | 0.02% | 0.00% |